26 research outputs found
Regional development gaps in Argentina: A multidimensional approach to identify the location of policy priorities
Spatial inequalities within Latin American countries have historically attracted the interest ofacademics, policy-makers, and international agencies. This article aims to provide amultidimensional diagnosis of provincial development gaps in Argentina, in order to identifythe location of policy priorities. Therefore, we built a large database, which covers sevendevelopment dimensions, and applied multivariate analysis techniques to overcome someanalytical limitations of previous studies. Results show the stability of provincial developmentgaps between 2003 and 2013 and some heterogeneity within geographic regions. Instead,cluster analysis offers a better classification of Argentine provinces according to theirdevelopment gaps, which can help the government to prioritize the places wheredevelopment policies are strategic.Fil: Niembro, Andrés Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina. Universidad Nacional de Río Negro; ArgentinaFil: Sarmiento, Jesica Isabel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina. Universidad Nacional de Río Negro; Argentin
Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study
Background: Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive neurodegenerative disease caused by mutations in either the NPC1 or NPC2 genes. The diagnosis of NP-C remains challenging due to the non-specific, heterogeneous nature of signs/symptoms. This study assessed the utility of plasma chitotriosidase (ChT) and Chemokine (C-C motif) ligand 18 (CCL18)/pulmonary and activation-regulated chemokine (PARC) in conjunction with the NP-C suspicion index (NP-C SI) for guiding confirmatory laboratory testing in patients with suspected NP-C. Methods: In a prospective observational cohort study, incorporating a retrospective determination of NP-C SI scores, two different diagnostic approaches were applied in two separate groups of unrelated patients from 51 Spanish medical centers (n = 118 in both groups). From Jan 2010 to Apr 2012 (Period 1), patients with =2 clinical signs/symptoms of NP-C were considered ''suspected NP-C'' cases, and NPC1/NPC2 sequencing, plasma chitotriosidase (ChT), CCL18/PARC and sphingomyelinase levels were assessed. Based on findings in Period 1, plasma ChT and CCL18/PARC, and NP-C SI prediction scores were determined in a second group of patients between May 2012 and Apr 2014 (Period 2), and NPC1 and NPC2 were sequenced only in those with elevated ChT and/or elevated CCL18/PARC and/or NP-C SI =70. Filipin staining and 7-ketocholesterol (7-KC) measurements were performed in all patients with NP-C gene mutations, where possible. Results: In total across Periods 1 and 2, 10/236 (4%) patients had a confirmed diagnosis o NP-C based on gene sequencing (5/118 4.2%] in each Period): all of these patients had two causal NPC1 mutations. Single mutant NPC1 alleles were detected in 8/236 (3%) patients, overall. Positive filipin staining results comprised three classical and five variant biochemical phenotypes. No NPC2 mutations were detected. All patients with NPC1 mutations had high ChT activity, high CCL18/PARC concentrations and/or NP-C SI scores =70. Plasma 7-KC was higher than control cut-off values in all patients with two NPC1 mutations, and in the majority of patients with single mutations. Family studies identified three further NP-C patients. Conclusion: This approach may be very useful for laboratories that do not have mass spectrometry facilities and therefore, they cannot use other NP-C biomarkers for diagnosis
A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)
Meeting abstrac
First-line management of metastatic urothelial cancer: Current and future perspectives after the EV-302 and CcheckMate-901 studies
The standard of care for the first-line management of metastatic urothelial carcinoma has been recently challenged, with
the combination of pembrolizumab and enfortumab vedotin (P-EV) strongly arising as a practice-changing option from
classical platinum-based chemotherapies. With this paradigm shift on the horizon new questions, including the most
suitable second line of treatment for these patients, and the role that the molecular characterization of these tumours
will have when selecting these therapies will inevitably arise. Furthermore, after the negative results of the Keynote
361 and IMvigor 130 trials, the combination of nivolumab with platinum-based chemotherapy followed by nivolumab
maintenance (Nivo GC-Nivo) has also shown positive results when compared with chemotherapy alone. Translational
studies at a molecular, cellular, and functional level will be key to better explain these discordant results. In this Current
Perspective, we discuss the potential impact of these results in clinical practice and propose specific guidance for
prospective translational research
Phase Behavior of an Extended Surfactant in Water and a Detailed Characterization of the Dilute and Semidilute Phases
The formation of microemulsions with triglycerides under ambient conditions was a challenge for scientists for many decades. For this reason, so-called extended surfactants were developed that contained hydrophilic/lipophilic linkers to stretch further into the oil and water phase, and enhance the soly. of triglycerides in water. Currently, only limited information about the properties of these surfactants and its behavior in water is available. Therefore, mixts. of a chosen extended surfactant (C12-14-PO16-EO2-SO4Na, X-AES) with H2O/D2O over the whole concn. range were studied by optical microscopy. A schematic phase diagram was obtained, which shows two isotropic liq. phases at the lowest and highest surfactant concns. Also, between the isotropic solns., four liq.-cryst. phases occur: a hexagonal phase (H1), a lamellar phase (L.alpha.) with a change in birefringence, a bicontinuous cubic phase (V2), and a reverse hexagonal phase (H2). The structure of the micellar soln. (L1) was detd. by cryo-TEM, dynamic light scattering, and 1H NMR, which gave information about the size, the aggregation no., and the area per mol. of the micelles. Liq.-crystal formation occurs from the micellar soln. in two different ways. The 1st route appeared by increasing the temp., going from an L1 to an L.alpha. phase. By increasing the surfactant concn. (at low temps.), a 2nd route showed a transition from L1 to H1. The effect of sodium chloride on the cloud point of the extended surfactant was examd., indicating that small amts. of NaCl have no influence on the phase behavior. The monolayer behavior of the extended surfactant at the air-water interface was also detd. Despite its water soly., an isotherm on the water subphase was found, showing slow kinetics of the mols. to go into the bulk. Thus, the detn. of the cmc of the extended surfactant using conventional methods is impossible
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Background: Myeloid-derived suppressor cells (MDSCs) are relevant in prostate cancer microenvironment
collaborating in tumor development. The main tumor marker used in this disease, prostate-specific antigen
(PSA), does not provide information related to this tumor microenvironment. Cancer cells secrete exosomes
carrying bioactive molecules contributing to MDSCs recruitment and induction. The aim of this study was to
characterize the perioperative changes of exosomal cytokines relevant in MDSCs recruitment induced by pros-
tatectomy in prostate cancer patients.
Methods: Blood was drawn from 26 early-stage prostate cancer patients before and after radical prostatectomy
and from 16 healthy volunteers. Serum exosomes were separated by precipitation. Cytokines related with MDSC
cell recruitment and activation CCL2, CXCL2, CXCL5, CXCL8, CXCL12, MIF, S100A9 and TGF-ß were measured
in serum and serum-derived exosomes using immunometric assays.
Results: All cytokines were detected both in serum and exosomes, except for CXCL12, which was detected only in serum. Exosomes were enriched specially in MIF, TGF-ß and CXCL2. Presurgical MIF levels in exosomes correlated negatively with serum PSA. Also, presurgical TGF-ß decreased both in serum and exosomes as Gleason score rises. Patientś presurgical exosomes had increased CCL2, CXCL5 and TGF-ß levels than exosomes from healthy controls. These differences were not observed when cytokines were analyzed in serum, except for TGF-ß.Cytokine levels of CCL2, CXCL5 decreased in patients’ postsurgical exosomes, while TGF-ß further increased. On the contrary, S100A9 levels were lower in patientś presurgical exosomes but increased after radical prostatectomy.
Conclusions: Blood exosomal content in cytokines constitute an attractive source to evaluate MDSCs immuno-
modulators providing additional information related to tumor microenvironment in prostate cance
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Background: Myeloid-derived suppressor cells (MDSCs) are relevant in prostate cancer microenvironment
collaborating in tumor development. The main tumor marker used in this disease, prostate-specific antigen
(PSA), does not provide information related to this tumor microenvironment. Cancer cells secrete exosomes
carrying bioactive molecules contributing to MDSCs recruitment and induction. The aim of this study was to
characterize the perioperative changes of exosomal cytokines relevant in MDSCs recruitment induced by pros-
tatectomy in prostate cancer patients.
Methods: Blood was drawn from 26 early-stage prostate cancer patients before and after radical prostatectomy
and from 16 healthy volunteers. Serum exosomes were separated by precipitation. Cytokines related with MDSC
cell recruitment and activation CCL2, CXCL2, CXCL5, CXCL8, CXCL12, MIF, S100A9 and TGF-ß were measured
in serum and serum-derived exosomes using immunometric assays.
Results: All cytokines were detected both in serum and exosomes, except for CXCL12, which was detected only in serum. Exosomes were enriched specially in MIF, TGF-ß and CXCL2. Presurgical MIF levels in exosomes correlated negatively with serum PSA. Also, presurgical TGF-ß decreased both in serum and exosomes as Gleason score rises. Patientś presurgical exosomes had increased CCL2, CXCL5 and TGF-ß levels than exosomes from healthy controls. These differences were not observed when cytokines were analyzed in serum, except for TGF-ß.Cytokine levels of CCL2, CXCL5 decreased in patients’ postsurgical exosomes, while TGF-ß further increased. On the contrary, S100A9 levels were lower in patientś presurgical exosomes but increased after radical prostatectomy.
Conclusions: Blood exosomal content in cytokines constitute an attractive source to evaluate MDSCs immuno-
modulators providing additional information related to tumor microenvironment in prostate cance